Cargando…
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety
Beginning in December of 2019, a novel coronavirus, SARS-CoV-2, emerged in China and is now a global pandemic with extensive morbidity and mortality. With the emergence of this threat, an unprecedented effort to develop vaccines against this virus began. As vaccines are now being introduced globally...
Autores principales: | Black, Steven B., Law, Barbara, Chen, Robert T., Dekker, Cornelia L., Sturkenboom, Miriam, Huang, Wan-Ting, Gurwith, Marc, Poland, Greg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936550/ https://www.ncbi.nlm.nih.gov/pubmed/33846042 http://dx.doi.org/10.1016/j.vaccine.2021.03.016 |
Ejemplares similares
-
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020
por: Moll, Keran, et al.
Publicado: (2023) -
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines
por: Pillsbury, Alexis, et al.
Publicado: (2023) -
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions
por: Dodd, Caitlin, et al.
Publicado: (2021) -
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
por: Willame, C, et al.
Publicado: (2023) -
Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project
por: de Bie, Sandra, et al.
Publicado: (2015)